Results 241 to 250 of about 933,669 (299)

Knowledge, Attitudes, and Uptake of Cervical Cancer Screening Among Female Students and Staff at a Tertiary Institution in Northern Uganda: A Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Cervical cancer remains a leading cause of cancer‐related deaths among women in low‐resource settings like Uganda. Screening is essential for early detection and prevention, yet knowledge, attitudes, and uptake among university females are poorly understood.
Milton Anguyo, Morrish Obol Okello, David Komakec, Emmanuel Alyoomu, Habert Aziku, Ruth Catherine Ouma, Pebalo Francis Pebolo   +6 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human papillomavirus infection

Disease-a-Month, 2016
Human papillomavirus (HPV) is a DNA virus that causes a variety of conditions including common warts, condyloma acuminata (anogenital warts), and multiple malignancies involving the squamous epithelium. HPV is a unique oncogenic infectious agent that causes cervical cancer, the second most common cancer in women worldwide.
Jack N, Hutter, Catherine F, Decker
openaire   +2 more sources

Human Papillomavirus Infections

Advances in Pediatrics, 1992
Though the existence of disease associated with HPV has been documented for centuries, it has been only within the past 2 decades that we have recognized the clinical diversity and significant morbidity and mortality associated with HPV infections.
openaire   +2 more sources

Pernicious Papillomavirus Infection

New England Journal of Medicine, 1999
More than 100 years have passed since an association between sexual behavior and cancer of the cervix was reported. In the ensuing years, the elusive sexually transmitted agent has been intensively sought. It was not long ago that the herpes simplex virus (HSV) was thought to be this agent on the basis of serologic studies, and indeed, HSV remains in ...
openaire   +2 more sources

Immunology of papillomavirus infection

Current Opinion in Immunology, 1996
Studies of the immunology of papillomavirus infection have come of age. Synthetic virus-like particles have been validated as vaccines for several animal papillomaviruses, and have been used to map the sero-epidemiology of human papillomavirus infection and to define papillomavirus neutralizing antibodies.
openaire   +5 more sources

Human papillomavirus infection

Journal of the American Academy of Dermatology, 1990
The human papillomavirus, well known as the etiologic agent of warts, has recently received much attention in the medical literature for its association with various cancers. This article discusses the virology, epidemiology, pathogenesis, immunology, clinical manifestations, and therapy for human papillomavirus infection.
openaire   +2 more sources

Persistent papillomavirus infection in a cat

Journal of the American Animal Hospital Association, 1996
A seven-year-old, neutered male, crossbred Persian was diagnosed as having persistent, cutaneous papillomavirus infection. The skin lesions consisted of round, multifocal-to-confluent, raised, black plaques on the neck, thorax, shoulders, and forelegs.
F, Lozano-Alarcón, T P, Lewis, E G, Clark, G A, Bradley, M R, Shupe, A M, Hargis   +5 more
openaire   +2 more sources

Human papillomavirus infection

Journal of the American Academy of Dermatology, 1989
Of porri, verucae, and eondylomata of the pudenda. There remains a fourth species of venereal disease to be added to those which we have already described, viz, warty excrescences of the genitals, which sometimes succeed impure coition, but for the most part follow other porky disorders that have been iU managed. Sometimes they wither of themselves and
openaire   +2 more sources

Vaccines for papillomavirus infection

Virus Research, 2002
Vaccines to prevent PV infection, utilising PV L1 virus like particles (VLPs) to induce neutralising antibody, are in clinical trial and show all the characteristics likely to be associated with success. Results warrant global planning for the deployment of VLP vaccines within a decade, as part of a program to prevent cervical cancer. Vaccines designed
openaire   +5 more sources

THERAPEUTIC APPROACHES TO PAPILLOMAVIRUS INFECTIONS

Dermatologic Clinics, 1997
Human papillomaviruses (HPVs) cause benign tumors (i.e., warts) and are occasionally responsible for malignant tumors such as squamous-cell carcinomas. Therapy for most warts is commonly via surgical or cytodestructive methods. Presently, only one antiviral/immunomodulatory drug is available for wart therapy; this agent, interferon alpha (IFN alpha ...
G E, Baker, S K, Tyring
openaire   +2 more sources